Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03184701 · ClinicalTrials.gov registry record · NA
Monitoring of Symptoms and Cognitive Function Using Telehealth
A NA study, sponsored by Albert Einstein Healthcare Network.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03184701 is a NA study that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 45 participants.
The verdict
NCT03184701, a NA study, has completed, sponsored by Albert Einstein Healthcare Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
End-Stage Liver Disease (ESLD) is one of the ten leading causes of death in US. It is marked by episodic acute exacerbations of the underlying liver disease which often leads to severe symptoms, poor quality of life, mental deterioration and repeated hospitalizations. The overall purpose of this project is to introduce a telehealth based intervention (involving remote monitoring of symptoms and cognitive function initiated at the time of discharge of ESLD patients. This will support enhanced clinical care and improve self-management in ESLD population. In addition, it will reduce healthcare utilization, improve medication adherence and overall health outcomes
Interventions
- OTHER Telehealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-04-30 |
| Est. Completion | 2018-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03184701
The ClinicalTrials.gov registry entry for NCT03184701 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telehealth is the first listed.
NCT03184701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03184701 about?
NCT03184701 is a clinical study titled "Monitoring of Symptoms and Cognitive Function Using Telehealth". End-Stage Liver Disease (ESLD) is one of the ten leading causes of death in US. It is marked by episodic acute exacerbations of the underlying liver disease which often leads to severe symptoms, poor quality of life, mental deterioration and repeated hospitalizations. The overall purpose of this pr...
What is the current status of trial NCT03184701?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-04-30. Estimated completion is 2018-08-30.
What interventions are being tested in trial NCT03184701?
The interventions under investigation include: Telehealth (OTHER).
Who is sponsoring clinical trial NCT03184701?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.